O
RVNC

OrbiMed’s Revance Therapeutics, Inc. RVNC Stock Holding History

OrbiMed’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100,000
Closed -$2.53M – 134
2023
Q2 		$2.53M Buy
100,000
+50,000
+100% +$1.27M 0.05% 108
2023
Q1 		$1.61M Buy
+50,000
New +$1.61M 0.03% 109